CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 101 filers reported holding CONSTELLATION PHARMCETICLS I in Q1 2020. The put-call ratio across all filers is 0.24 and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $54,128,000 | +35.4% | 1,601,427 | -6.3% | 0.96% | +14.4% |
| Q1 2021 | $39,973,000 | -4.9% | 1,708,957 | +17.1% | 0.84% | +1.2% |
| Q4 2020 | $42,018,000 | +106.3% | 1,458,957 | +45.1% | 0.83% | +67.3% |
| Q3 2020 | $20,371,000 | -22.4% | 1,005,487 | +15.1% | 0.50% | -35.2% |
| Q2 2020 | $26,260,000 | -12.4% | 873,890 | -8.4% | 0.76% | -19.6% |
| Q1 2020 | $29,987,000 | +15.7% | 954,100 | +73.5% | 0.95% | +15.1% |
| Q4 2019 | $25,911,000 | +16946.7% | 550,000 | +2230.5% | 0.83% | +13683.3% |
| Q3 2019 | $152,000 | -93.3% | 23,600 | -87.1% | 0.01% | -92.6% |
| Q2 2019 | $2,255,000 | -34.3% | 183,600 | -27.5% | 0.08% | -38.6% |
| Q1 2019 | $3,434,000 | +34.7% | 253,400 | -60.1% | 0.13% | +29.4% |
| Q4 2018 | $2,550,000 | -40.4% | 635,843 | 0.0% | 0.10% | -33.3% |
| Q3 2018 | $4,279,000 | – | 635,843 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi II Management, LLC | 1,574,229 | $45,338,000 | 33.03% |
| Ponoi Management, LLC | 1,880,623 | $54,162,000 | 30.99% |
| VR Adviser, LLC | 4,016,873 | $115,686,000 | 17.01% |
| Column Group LLC | 2,626,631 | $75,647,000 | 6.86% |
| COMMODORE CAPITAL LP | 423,708 | $12,203,000 | 6.64% |
| GREAT POINT PARTNERS LLC | 1,024,800 | $29,514,000 | 4.79% |
| Venrock Management V, LLC | 1,557,276 | $44,850,000 | 4.23% |
| Ghost Tree Capital, LLC | 625,000 | $18,000,000 | 4.01% |
| Euclidean Capital LLC | 554,325 | $15,965,000 | 3.38% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 737,406 | $21,237,000 | 3.07% |